HUP1100444A2 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number: HUP1100444A2
Authority: HU; Hungary
Prior art keywords: pharmaceutical composition; pharmaceutical; composition
Prior art date: 2011-08-17

Application number

HU1100444A

Other languages

Hungarian (hu)

Inventor

Ahmed Dr Sabry

Attila Dr Kolonics

Janos Egri

Laszlo Dr Vigh

Gordon Department Of Phisiology Dr Linch

Stefan Department Of Physiology Dr Gehrig

Lars Dr Larson

Kalman Dr Tory

Nagy Peter Dr Literati

Mark Dr Febbraio

Original Assignee

Pharma Gene Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-08-17

Filing date

2011-08-17

Publication date

2013-02-28

2011-08-17 Application filed by Pharma Gene Sa filed Critical Pharma Gene Sa

2011-08-17 Priority to HU1100444A priority Critical patent/HUP1100444A2/en

2012-08-14 Priority to PCT/HU2012/000070 priority patent/WO2013024311A1/en

2013-02-28 Publication of HUP1100444A2 publication Critical patent/HUP1100444A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HU1100444A 2011-08-17 2011-08-17 Pharmaceutical composition HUP1100444A2 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
HU1100444A HUP1100444A2 (en)	2011-08-17	2011-08-17	Pharmaceutical composition
PCT/HU2012/000070 WO2013024311A1 (en)	2011-08-17	2012-08-14	Amidoxime derivatives for the prevention and/or treatment of muscle atrophy

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU1100444A HUP1100444A2 (en)	2011-08-17	2011-08-17	Pharmaceutical composition

Publications (1)

Publication Number	Publication Date
HUP1100444A2 true HUP1100444A2 (en)	2013-02-28

Family

ID=89990395

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU1100444A HUP1100444A2 (en)	2011-08-17	2011-08-17	Pharmaceutical composition

Country Status (2)

Country	Link
HU (1)	HUP1100444A2 (en)
WO (1)	WO2013024311A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3263105A1 (en)	2016-07-01	2018-01-03	Montana State University	Use of bgp15 to treat familial dysautonomia
JP7270979B2 (en)	2017-06-08	2023-05-11	エヌ－ジーンリサーチラボラトリーズ，アイエヌシー．	Methods of treating NASH and preventing NASH-induced HCC
HUP1800298A1 (en)	2018-08-30	2020-05-28	N Gene Res Laboratories Inc	Combination of beta blocker and hydroximic acid derivative with reduced side effects

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4187220A (en)	1977-08-30	1980-02-05	Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T.	New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU9502843D0 (en)	1995-09-29	1995-11-28	Livigene Ltd	Pharmaceutical composition
US6458371B1 (en)	1995-12-22	2002-10-01	Medgene, Limited	Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin
US6884424B2 (en)	1995-12-22	2005-04-26	N-Gene Research Laboratories Inc.	Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
HU9701081D0 (en)	1997-06-23	1997-08-28	Gene Research Lab Inc N	Pharmaceutical composition of antitumoral activity
HUP9701080A3 (en)	1997-06-23	1999-05-28	Gene Res Lab Inc New York N	Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative
WO2000007580A2 (en)	1998-08-03	2000-02-17	N-Gene Kutató Kft.	Pharmaceutical compositions against autoimmune diseases
DE60103140T2 (en)	2000-03-20	2005-05-04	N-Gene Research Laboratories Inc.	PROPANCARBOXYLIC ACID DERIVATIVES, A METHOD OF PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS WHICH EMBELLISHED THEM
WO2003007951A1 (en)	2001-07-17	2003-01-30	N-Gene Research Laboratories Inc.	A synergistic pharmaceutical combination for the prevention or treatment of diabetes
HUP0401176A2 (en)	2004-06-14	2007-09-28	N Gene Res Lab Inc	Pharmaceutical composition having prpkinetic effect
HUP0401177A2 (en)	2004-06-14	2007-09-28	N Gene Res Lab Inc	Pharmaceutical composition for increasing the mitochondrial genesis
HUP0500145A2 (en)	2005-01-28	2006-11-28	Gene Res Lab N	Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases
US20080108602A1 (en)	2006-11-02	2008-05-08	N-Gene Research Laboratories, Inc.	Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication
US7763601B2 (en)	2006-11-02	2010-07-27	N-Gene Research Laboratories, Inc.	Prevention and treatment of obesity
WO2009074835A1 (en)	2007-12-10	2009-06-18	N-Gene Research Laboratories Inc.	Dose reduction of a cannabinoid cb1 receptor antagonist in the treatment of overweight or obesity

2011
- 2011-08-17 HU HU1100444A patent/HUP1100444A2/en unknown
2012
- 2012-08-14 WO PCT/HU2012/000070 patent/WO2013024311A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2013024311A1 (en)	2013-02-21

Publication	Publication Date	Title
AP3864A (en)	2016-10-31	Pharmaceutical composition
GB201113662D0 (en)	2011-09-21	Pharmaceutical compositions
AP3656A (en)	2016-04-04	Pharmaceutical compositions
ZA201308208B (en)	2014-06-25	Pharmaceutical compositions
GB201118232D0 (en)	2011-12-07	Pharmaceutical composition
PL2776416T3 (en)	2017-01-31	Pharmaceutical compounds
ZA201501930B (en)	2016-01-27	Pharmaceutical composition
EP2832730A4 (en)	2015-09-09	Mirabegron-containing pharmaceutical composition
ZA201308157B (en)	2015-01-28	Pharmaceutical composition
GB201119799D0 (en)	2011-12-28	Pharmaceutical compounds
ZA201403832B (en)	2016-02-24	Pharmaceutical compounds
GB201118876D0 (en)	2011-12-14	Pharmaceutical compounds
GB201113163D0 (en)	2011-09-14	Pharmaceutical compounds
EP2727593A4 (en)	2014-11-26	Nicorandil-containing pharmaceutical composition
GB201118181D0 (en)	2011-12-07	Pharmaceutical compositions
EP2711010A4 (en)	2015-04-15	Pharmaceutical composition
ZA201502987B (en)	2016-11-30	Pharmaceutical composition
HUP1100444A2 (en)	2013-02-28	Pharmaceutical composition
ZA201308414B (en)	2015-05-27	Solid pharmaceutical composition
HUP1100445A2 (en)	2013-02-28	Pharmaceutical composition
ZA201309537B (en)	2015-04-29	Pharmaceutical composition comprising fexofedine
GB201105224D0 (en)	2011-05-11	Novel pharmaceutical compositions
ZA201400751B (en)	2014-12-25	Pharmaceutical composition
GB201119796D0 (en)	2011-12-28	Pharmaceutical comopounds
GB201120735D0 (en)	2012-01-11	New pharmaceutical uses

Legal Events

Date	Code	Title	Description
2013-12-30	FD9A	Lapse of provisional protection due to non-payment of fees
2017-10-30	GB9A	Succession in title	Owner name: PHARMA-GENE SA, CH Free format text: FORMER OWNER(S): DR. HAZAY BALAZS, HU

Date

Code

Title

Description

2013-12-30

FD9A

Lapse of provisional protection due to non-payment of fees

2017-10-30

GB9A

Succession in title

Owner name: PHARMA-GENE SA, CH

Free format text: FORMER OWNER(S): DR. HAZAY BALAZS, HU